Business Context and Reporting Period
SciSparc Ltd., a foreign private issuer based in Tel Aviv, Israel, filed Form 6-K on January 13, 2026. The filing announces a registered direct offering of ordinary shares to institutional and accredited investors.
Key Financial Metrics
- Gross Proceeds: Approximately $766,170.
- Shares Issued: 766,170 Ordinary Shares.
- Price Per Share: $1.00.
- Use of Proceeds: Working capital and general corporate purposes.
- Revenue, Profit, Cash Flow, Margins, Debt, Liquidity: The filing text does not provide a clear value for these operational or balance sheet metrics.
Material Changes
This filing represents a capital raise event rather than a periodic financial report. Consequently, there are no comparative financial metrics or material changes in operating performance versus a prior period disclosed in this document.
Outlook, Risks, and Unusual Items
- Closing Date: Expected on or about January 14, 2026.
- Regulatory Framework: Issuance is pursuant to a prospectus supplement under a shelf registration statement (Form F-3) declared effective on February 23, 2023.
- Risks and Forward-Looking Statements: The filing includes standard disclaimers that actual results may differ materially from expectations due to inherent uncertainties. Investors are directed to the risks described in the Company's Form 20-F for the year ended December 31, 2024.
- Legal Provisions: The Purchase Agreement includes customary representations, warranties, indemnification for liabilities under the Securities Act of 1933, and rights of contribution.
Investor Verification Checklist
- Verify the final closing date and actual net proceeds after deducting transaction costs.
- Review the full Securities Purchase Agreement (Exhibit 10.1) for specific covenants or restrictions.
- Examine the Company's most recent Form 20-F (filed April 24, 2025) for detailed financial condition and risk factors.
- Confirm the dilution impact of the 766,170 new shares on existing shareholders.